Hong Kong poised to benefit as US considers delisting Chinese firms
A total of 286 Chinese firms are listed in the US with a total market capitalisation of US$1.1 trillion.
BON Announces Apple Polyphenol Commercial Order Signed - Bon Natural Life ( NASDAQ:BON )
XI'AN, China, April 11, 2025 ( GLOBE NEWSWIRE ) -- Bon Natural Life Limited BON ( "BON" or the "Company" ) , a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a groundbreaking 24-month supply agreement worth $12M with Shanghai Yunsheng, ...
Optima Health to acquire Cognate Health Limited
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations ( EU ) No. 596/2014 as amended by regulation 11 of the Market Abuse ( Amendment ) ( EU Exit ) Regulations 2019/310.
Northland Power Announces its First Quarter 2025 Financial Results Release Date and Provides Investor Call and Webcast Details
TORONTO, April 11, 2025 ( GLOBE NEWSWIRE ) -- Northland Power Inc. ( "Northland" ) ( TSX: NPI ) announces it will release its 2025 first quarter operating and financial results after markets close on Tuesday, May 13, 2025. Northland's management will hold an investor conference call and webcast ...
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April ...
Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9 - Verve Therapeutics ( NASDAQ:VERV )
BOSTON, April 11, 2025 ( GLOBE NEWSWIRE ) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that the U.S.
Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
BOSTON, April 11, 2025 ( GLOBE NEWSWIRE ) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that the U.S. Food and Drug Administration ( FDA ) has granted Fast Track designation for VERVE-102 for the treatment ...
Morgan Stanley to report first-quarter earnings - here's what to expect
Shares of Morgan Stanley, like those of its peers, have whipsawed in recent days amid President Donald Trump's trade policies.
